Noble Care Research is building the clinical infrastructure to understand Breast Implant Associated Illness (B.I.A.I.) and translate patient experience into validated, insurable care — at institutional scale.
The Numbers
A global issue. A measurable opportunity.
Women Worldwide
with breast implants, a significant global population.
Annual Procedures
Up to 7 million breast augmentation and reconstruction surgeries performed yearly.
Adverse Events
Reported to the U.S. Food and Drug Administration, indicating significant patient concerns.
Patient Voices
Shared experiences of symptoms across social media and patient communities.
Reported Symptoms
Across immune, neurological, endocrine, and systemic functions, highlighting complexity.
Beyond the statistics, the challenges are equally profound:
- Global Recognition: Implant-related cancers are acknowledged by the World Health Organization.
- No Standard of Care: A lack of unified diagnostic criteria or treatment protocols for Breast Implant Associated Illness.
- Limited Coverage: Many patients bear out-of-pocket costs for medically necessary explant surgeries due to insufficient insurance.
- Billions at Stake: In patient costs, insurer exposure, and the broad impact of untreated conditions.
The Opportunity
Define the data. Standardize the care. Unlock access.
Noble Care Research is building the clinical foundation to turn these numbers into outcomes.
The Data Exists. The System Does Not.
Millions of patients are navigating Breast Implant Associated Illness without a coordinated clinical framework to support them. The experiences are real. The burden is measurable. What remains missing is the infrastructure to capture, standardize, and act on it.
Fragmented Patient Experiences
Patients present across specialties with no shared protocol, no unified intake, and no longitudinal tracking — leaving critical clinical signals undocumented and unusable.
Lack of Clinical Standardization
Without standardized diagnostic criteria or outcome measures, B.I.A.I. remains poorly characterized across providers — limiting research quality and care consistency.
No Unified Dataset
Existing data is siloed across health systems, private practices, and patient communities — none of it structured for research-grade analysis or regulatory submission.
Limited Insurance Coverage
Without peer-reviewed outcomes data, payers lack the clinical basis to authorize and reimburse B.I.A.I.-related care — creating structural access barriers for patients nationwide.
Turning Patient Experience Into Clinical Evidence
Noble Care Research exists to close the gap between lived patient experience and the clinical evidence systems require. We do this by building the data infrastructure, research partnerships, and validation frameworks that transform B.I.A.I. from an underrecognized condition into a clinically documented, insurable, and systematically treatable diagnosis.
Our approach is grounded in four imperatives: structured data collection, clinical validation at scale, real-world outcomes measurement, and alignment with payer and insurance frameworks. Every initiative we build is designed to produce evidence that moves through the healthcare system — not around it.
What We Are Building
Four interconnected pillars form the foundation of Noble Care Research's clinical infrastructure — each designed to be scalable, interoperable, and investment-grade from day one.
Patient Registry
A structured, longitudinal registry capturing standardized patient-reported and clinician-documented data across the B.I.A.I. spectrum — the foundational dataset for all downstream research.
Clinical Partnerships
Formal institutional relationships with health systems, academic medical centers, and specialty practices to enable multi-site data collection and co-authored research publication.
Outcomes Research
Rigorous, IRB-compliant studies measuring clinical, functional, and quality-of-life outcomes — generating the peer-reviewed evidence base required by payers, regulators, and guideline bodies.
Evidence for Better Care
Translating validated outcomes data into payer-ready dossiers, clinical coverage arguments, and reimbursement pathways — aligning the research output with system-level access and coverage decisions.
Who We Serve
Noble Care Research functions as a clinical infrastructure platform serving a structured ecosystem of stakeholders — each engaging with our data and research outputs in distinct, complementary ways.
Patients
Women navigating B.I.A.I. gain access to structured care pathways, registry enrollment, and advocacy tools grounded in clinical evidence — not anecdote.
Physicians
Clinicians gain access to validated diagnostic frameworks, collaborative research opportunities, and outcomes benchmarking tools that elevate practice standards.
Researchers
Academic and industry investigators access a curated, research-grade dataset and a partner network built for multi-site collaboration and high-impact publication.
Healthcare Systems & Insurers
Health systems and payers receive structured evidence outputs — outcomes data, utilization analyses, and coverage arguments — that enable informed, defensible coverage decisions for B.I.A.I. care.
Built Within an Integrated Care Ecosystem
Noble Care Research does not operate in isolation. It is the clinical intelligence layer within Noble Care — a fully integrated ecosystem designed to serve patients, providers, and partners at every touchpoint of the B.I.A.I. care continuum.
Each entity within the Noble Care ecosystem is purpose-built and operationally distinct — yet architecturally unified. Research informs AI. AI informs the Network. The Network informs care delivery. And community data flows back into research. This is not a portfolio of projects. It is a system.
Join Us in Building the Future of Women's Health
Noble Care Research is actively seeking institutional partners, clinical collaborators, research co-investigators, and strategic investors who recognize the scale of the unmet need — and the significance of the infrastructure we are building to address it.
Clinical Partnership
Health systems, academic medical centers, and specialty practices interested in co-developing B.I.A.I. research protocols and contributing to the patient registry.
Institutional Research Collaboration
IRB-compliant co-investigator relationships with researchers and biostatisticians aligned on outcomes measurement and payer evidence generation.
Strategic & Commercial Partnerships
Medical device manufacturers, insurers, and health technology companies seeking access to structured B.I.A.I. outcomes data and evidence-based coverage pathways.
Advancing Clinical Understanding. Expanding Access to Care.